Harbor review
Each plan states what it covers. Each figure carries the words as low as.
The verdict
Harbor publishes as low as $89 a month for compounded semaglutide and $119 for tirzepatide. Each plan covers medication, provider consultations, refill management and shipping.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $89/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Harbor sells both molecules as a weekly injection. Each figure is bundled. Four things are named as included.
Who writes the prescription, and what do they see?
Provider consultations are named as included in both plans. No clinician is described. The intake is not documented.
Naming four inclusions is a real disclosure. Refill management is unusual to see itemized. What the words as low as do to all of it is the offsetting problem.
What happens when the dose goes up?
Nothing is published about dose. A bundled floor with no milligram attached cannot be compared against a rate that carries one. The inclusions are stated; the dose is not.
What the price includes
$89 and $119 are floors rather than rates. Six months at them is $534 and $714 at best. The site states no price increases, but what sets the floor is not published. Ask for the figure at a therapeutic dose before ordering.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Four inclusions named in each plan
- Strength: Refill management itemized explicitly
- Strength: Both molecules carry a figure
- Limitation: Both figures are a floor, not a rate
- Limitation: No milligram dose stated anywhere
- Limitation: No state coverage list is recorded
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Harbor. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who values a bundled plan and will ask what raises the floor.
- Wrong for
- A reader budgeting six months from $89.
The evidence behind what Harbor prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Harbor compares
| Seller | Who it suits | Go |
|---|---|---|
 Green Cap Health | Readers in Texas wanting the lowest published figures | See Green Cap Health → |
 Glam Health | Readers who will ask what the plan costs at their own dose | See Glam Health → |
 Get Thin MD | Readers taking the three-month plan who read what the sale actually covers | See Get Thin MD → |
More GLP-1 telehealth sellers reviews: Vea HealthVela RxVergeVida HealthVirgo-MedsVirta Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What is included?
- Medication, provider consultations, refill management and shipping, named in both plans.
- Is $89 a rate?
- No. It is a floor. Both figures carry the words as low as, and what sets them is not published.
- What dose does it cover?
- No milligram figure is published beside either price.
- Is Harbor expensive compared with other GLP-1 telehealth sellers?
- Harbor publishes a starting figure of $89/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Harbor below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.